Risk of Falling and Cardiac Rehabilitation
CARDIO-BALANCE
Risk of Falling Assessment in a Population of Patients With Cardiovascular Diseases Undergoing Cardiac Rehabilitation
1 other identifier
interventional
150
1 country
1
Brief Summary
Background and Rationale Cardiac rehabilitation (CR) is a key intervention for patients with chronic heart disease or recent acute cardiovascular events. In elderly and frail patients, CR aims not only to improve functional capacity but also to maintain or recover independence in daily activities. Hospitalization following an acute event often leads to bed rest, which-even after just 2-3 days-can cause hypokinetic syndrome, characterized by loss of muscle tone, orthostatic hypotension, decreased mobility, and psychological decline, including depression. Moreover, immobility increases thrombotic risk and vascular complications. To mitigate these effects, CR is initiated promptly after clinical stabilization and includes three phases:
- 1.Phase I - In-hospital rehabilitation
- 2.Phase II - Early outpatient rehabilitation
- 3.Phase III - Long-term maintenance Elderly patients are particularly vulnerable to falls due to the combined effects of reduced muscle strength, orthostatic hypotension, cognitive decline, and pre-existing sarcopenia-often exacerbated by acute events and immobility. Approximately 60% of cardiac patients hospitalized for acute events present with moderate-to-high fall risk. Fall risk in this population is multifactorial, involving cardiovascular issues (e.g., arrhythmias, orthostatic hypotension), medication effects, and non-cardiac factors such as vision loss, balance impairment, neuromuscular conditions, and cognitive deficits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 31, 2024
CompletedFirst Submitted
Initial submission to the registry
March 26, 2025
CompletedFirst Posted
Study publicly available on registry
April 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedApril 3, 2025
April 1, 2025
12 months
March 26, 2025
April 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the effect of cardiac rehabilitation on the risk of falling in elderly cardiac patients following a recent acute event requiring hospitalization.
The risk of falling will be assessed through the Conley scale. We will consider the percentage changes in the score obtained in the Conley scale at different evaluation times in relation to the study design
Fron enrollment to the end of the in-hospital phase and after 12 weeks from discharge
Study Arms (2)
supervised exercise in cardiac rehabilitation
EXPERIMENTALgroup 1: patients will perform supervised exercise training in the gym of San Raffaele IRCCS of Rome
home-based exercise
ACTIVE COMPARATORgroup 1: patients will be asked to perform not supervised exercise training at home according to european guidelines for people with cardiovascular diseases
Interventions
In the first phase of the study all enrolled patients will perform exercise in the context of an in-hospital intesive rehabilitation after the acute event. At discharge they will be randomized in two groups: supervised exercise in the context of a cardiac rehabilitation facility or home-based exercise
Eligibility Criteria
You may qualify if:
- \- Age \> 65 years
- Recent acute cardiac event, including:
- Cardiac surgery (CABG, aortic and/or mitral valve replacement, mitral valvuloplasty, or combined CABG + valve surgery)
- Recent myocardial infarction treated with percutaneous revascularization
- Episode of acute heart failure
You may not qualify if:
- Persistent clinical instability, defined as:
- Marked hypotension (BP ≤ 95/60 mmHg) or hypertension (BP ≥ 160/100 mmHg)
- Bradycardia (HR \< 50 bpm) or tachycardia (HR \> 115 bpm)
- Resting dyspnea
- Signs and symptoms of infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCs San Raffaele
Rome, RM, 00166, Italy
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2025
First Posted
April 3, 2025
Study Start
May 31, 2024
Primary Completion
May 30, 2025
Study Completion
June 30, 2025
Last Updated
April 3, 2025
Record last verified: 2025-04